
Movement Disorders
The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA,
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA,
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD
by Uzma Ilyas, PhD scholar; Farwa Aslam, MS; Muqadas Fatima,
by Mark G. A. Opler, PhD, MPH; Amy Claxton, PhD*;
by Allison Zuckerberg, MD; Nitin Pothen, MD; and Adriana Fitzsimmons,
by Terry Correll, DO; Julie Gentile, MD; and Andrew Correll,
by Uzma Ilyas, PhD scholar, and Prof. Dr. Saima Dawood
by Aksha M. Memon, MBBS, MD, MPH; Jigar Katwala, MBBS,
by Akemini “Kem” Isang, RN, JD Ms. Isang is a
by Leslie Citrome, MD, MPH; Marko A. Mychaskiw, BSRPh, MS,